Elena Filimonova

Dr. Elena Filimonova

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Journal of Affective Disorders
Verified
Journal Article
Closed access
GKGennady Knyazev
Gennady Knyazev
ASAlexander N. Savostyanov
Alexander N. Savostyanov
ABAndrey V. Bocharov
Andrey V. Bocharov
IBIvan V. Brak
Ivan V. Brak
EOEvgeny A. Osipov
Evgeny A. Osipov
LALyubomir I. Aftanas
Lyubomir I. Aftanas

14 October 2022 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
EFElena Filimonova
Elena Filimonova
KOK. Ovsiannikov
K. Ovsiannikov
JRJ. Rzaev
J. Rzaev

19 July 2023 in Frontiers in Neuroscience
Verified
Journal Article
Open access
EFElena Filimonova
Elena Filimonova
APAnton A. Pashkov
Anton A. Pashkov
GMGalina I. Moysak
Galina I. Moysak
ATAnastasia Y. Tropynina
Anastasia Y. Tropynina
SZSvetlana Y. Zhanaeva
Svetlana Y. Zhanaeva
JRJamil A. Rzaev
Jamil A. Rzaev
Mesial temporal lobe epilepsy is the most common type of focal epilepsy, imposing a significant burden on the health care system worldwide. Approximately one-third of patients with this disease who do not adequately respond to pharmacotherapy are considered drug-resistant subjects. Despite having some clues of how such epileptic activity and resistance to therapy emerge, coming mainly from preclinical models, we still witness a scarcity of human data. To narrow this gap, in this study, we aimed to estimate the relationship between hippocampal and serum levels of brain-derived neurotrophic factor (BDNF), one of the main and most widely studied neurotrophins, and hippocampal subfield volumes in patients with drug-resistant mesial temporal epilepsy undergoing neurosurgical treatment. We found that hippocampal (but not serum) BDNF levels were negatively correlated with the contralateral volumes of the CA1 and CA4 subfields, presubiculum, subiculum, dentate gyrus, and molecular layer of the hippocampus. Taken together, these findings are generally in accordance with existing data, arguing for a proepileptic nature of BDNF effects in the hippocampus and related brain structures.

22 January 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
ALAugusto Leone
Augusto Leone
VNVeronica Di Napoli
Veronica Di Napoli
Nicola Pio FochiNicola Pio Fochi
Nicola Pio Fochi
Giuseppe Di PernaGiuseppe Di Perna
Giuseppe Di Perna
USUwe Spetzger
Uwe Spetzger
ACAntonio Colamaria
Antonio Colamaria
Background/Objectives: The methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) promoter in gliomas has emerged as a critical biomarker for prognosis and treatment response. Conventional methods for assessing MGMT promoter methylation, such as methylation-specific PCR, are invasive and require tissue sampling. Methods: A comprehensive literature search was performed in compliance with the updated PRISMA 2020 guidelines within electronic databases MEDLINE/PubMed, Scopus, and IEEE Xplore. Search terms, including “MGMT”, “methylation”, “glioma”, “glioblastoma”, “machine learning”, “deep learning”, and “radiomics”, were adopted in various MeSH combinations. Original studies in the English, Italian, German, and French languages were considered for inclusion. Results: This review analyzed 34 studies conducted in the last six years, focusing on assessing MGMT methylation status using radiomics (RD), deep learning (DL), or combined approaches. These studies utilized radiological data from the public (e.g., BraTS, TCGA) and private institutional datasets. Sixteen studies focused exclusively on glioblastoma (GBM), while others included low- and high-grade gliomas. Twenty-seven studies reported diagnostic accuracy, with fourteen achieving values above 80%. The combined use of DL and RD generally resulted in higher accuracy, sensitivity, and specificity, although some studies reported lower minimum accuracy compared to studies using a single model. Conclusions: The integration of RD and DL offers a powerful, non-invasive tool for precisely recognizing MGMT promoter methylation status in gliomas, paving the way for enhanced personalized medicine in neuro-oncology. The heterogeneity of study populations, data sources, and methodologies reflected the complexity of the pipeline and machine learning algorithms, which may require general standardization to be implemented in clinical practice.

5 March 2024 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
EFElena Filimonova
Elena Filimonova
MAMars Abdaev
Mars Abdaev
IVIvan Vasilenko
Ivan Vasilenko
YKYulij Kubetskij
Yulij Kubetskij
OPOleg Prokhorov
Oleg Prokhorov
JRJamil Rzaev
Jamil Rzaev

9 December 2023 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
EFElena Filimonova
Elena Filimonova
APAnton Pashkov
Anton Pashkov
GMGalina Moysak
Galina Moysak
AMAzniv Martirosyan
Azniv Martirosyan
BZBoris Zaitsev
Boris Zaitsev
JRJamil Rzaev
Jamil Rzaev